INDIA CARDIOVASCULAR MEDICAL DEVICES MARKET

INTRODUCTION

 These gadgets are used to diagnose and treat heart disease and other health issues. Cardiovascular technologies such as artificial heart valves, coronary stents, endovascular grafts, and angioplasty balloon catheters save countless lives each year and significantly improve the quality of life for millions of people.

 However, the design, development, and production of modern implantable cardiovascular devices is a complex, time-consuming, and capital-intensive process for device manufacturers.

Furthermore, because of the higher level of risk they pose to patients, cardiovascular devices are subject to extensive assessment and control by medical device authorities in the majority of large nations.

INDIA CARDIOVASCULAR MEDICAL DEVICES MARKET SIZE AND FORECAST

The India Cardiovascular Medical Devices market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

INDIA CARDIOVASCULAR MEDICAL DEVICES MARKET NEW PRODUCT LAUNCH

Wipro GE Healthcare recently introduced the country's first 'AI-enabled Made-in-India' Cath lab for enhanced cardiac treatment. Noncommunicable diseases (NCDs) account for 60% of all deaths in India, with cardiovascular diseases (CVDs), chronic respiratory illnesses, cancer, and diabetes accounting for 82% of all deaths.

The promises are that this new generation of interventional imaging software in the Optima IGS 320 offers clinical adaptability to guide advanced non-invasive procedures with improved precision. 

Automating the traditionally difficult process with Auto Right reduces the stress on interventionalists and may raise their attention to the procedure. The goal at Wipro GE Healthcare is to transition from health care to healthy ageing, which may be accomplished through predictive, preventative, and personalized medicine.

Because of the increasing complexity of patient profiles and fluctuating illness patterns, personalized treatment is becoming increasingly important, and Artificial Intelligence solutions have the potential to alter the patient care route.

 With this 'Made in India' AI-enabled Cath lab, they hope to drive intelligent imaging to assist cardiologists and patients with customized treatment protocols and therapies, as well as to increase access to quality healthcare throughout India.

According to the business, the Optima IGS320 medical gadget is designed for cardiac and electrophysiological operations and increases visualization across imaging to promote intelligent and precision healthcare delivery. It increases operational flexibility by allowing for friendly gantry movement.

INDIA CARDIOVASCULAR MEDICAL DEVICES MARKET COMPANY PROFILE

• Abbott Laboratories
• Boston Scientific
• Terumo Corporation
• W. L. Gore & Associates
• Medtronic PLC

THIS INDIA CARDIOVASCULAR MEDICAL DEVICES MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Cardiovascular Medical Devices are manufactured per annum India? Who are the sub-component suppliers in different regions?
2. Cost breakup of a India Cardiovascular Medical Devices and key vendor selection criteria
3. Where are the Cardiovascular Medical Devices manufactured? What is the average margin per unit?
4. Market share of India Cardiovascular Medical Devices market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture India Cardiovascular Medical Devices in-house
6. key predictions for next 5 years in India Cardiovascular Medical Devices market
7. Average B-2-B Cardiovascular Medical Devices market price in all segments
8. Latest trends in Cardiovascular Medical Devices market, by every market segment
9. The market size (both volume and value) of the Cardiovascular Medical Devices market in 2024-2030 and every year in between?
10. Production breakup of Cardiovascular Medical Devices market, by suppliers and their OEM relationship